Quick Answer
Burning Rock Biotech Ltd reported Research And Development Expense of $232.29 million for the year ending 2024.
- Burning Rock Biotech Ltd showed a decrease of -33.1% in Research And Development Expense from 2023 to 2024.
- This data is from Burning Rock Biotech Ltd's annual report (Form 10-K), filed with the SEC on April 29, 2025.
- XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2018 to 2024), Burning Rock Biotech Ltd's Research And Development Expense has grown by 120.6%.
- Historical annual values: Fiscal year 2024: $232.29 million | Fiscal year 2023: $347.02 million | Fiscal year 2022: $421.87 million | Fiscal year 2021: $367.86 million | Fiscal year 2020: $263.94 million | Fiscal year 2019: $156.94 million | Fiscal year 2018: $105.30 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: